The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Recruiting
CT.gov ID
NCT04336228
Collaborator
University of Cambridge (Other), Lundbeck Foundation (Other)
48
1
4
52
0.9

Study Details

Study Description

Brief Summary

The aim of this project is to investigate:
  • The status of the central serotonin (5-hydroxytryptamine, 5-HT) system in compulsive behaviour and how it is affected by sub-chronic escitalopram administration

  • The mechanisms underlying how sub-chronic administration of escitalopram affects the central 5-HT system

  • How changes in cognitive performance, including the balance between habitual and goal-directed mechanisms, are affected in compulsive behaviour by boosting 5-HT function

  • How functional brain changes in cognitive function measured with magnetic resonance imaging relate to altered 5-HT function following escitalopram administration.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

Previous studies have shown that 5-HT is strongly implicated in compulsive behaviours in experimental animals. Manipulation of 5-HT influences neuronal interactions underlying action selection. Reduced forebrain 5-HT causes perseveration and impairs goal-directed behaviour under reward but not punishment. Dysfunctional 5-HT neurotransmission has also been implicated in Obsessive-Compulsive Disorder (OCD) based on the selective efficacy of relatively high doses of selective serotonin reuptake inhibitors (SSRIs) in treating this disorder. Hitherto, it is unknown whether there is a primary defect in the serotonergic system or whether SSRIs ameliorate symptoms by modulating other brain neurotransmitter pathways. So far, only one study of central 5-HT release in OCD patients has been conducted and its methodology may be questioned.

A number of behavioural and cognitive features of OCD, including endophenotype markers that appear to characterise the disorder have been determined. These include a shift in cognitive control from a goal-directed strategy to a habitual (stimulus-response, S-R) strategy, cognitive rigidity in terms of both reversal learning and attentional set-shifting, impaired response inhibition and planning, and a tendency to over-respond to spurious negative feedback in a probabilistic learning paradigm. Neural substrates of these deficits are being investigated using brain imaging methodologies based on magnetic resonance and preliminary evidence suggests an over-active medial prefrontal cortex-caudate nucleus circuits and underactive lateral prefrontal cortex-putamen circuits. However, little evidence exists that relates to the hypothesis of an over-active habit system in this disorder or to the role of serotonin in all these cognitive and behavioural deficits observed in OCD and compulsivity in general.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms
Actual Study Start Date :
Apr 1, 2020
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Healthy Control Group

The healthy placebo control group will be administered the exact same procedure as the intervention group, the only difference being that this group will be administered a placebo tablet.

Drug: Placebo oral tablet
20mg placebo tablet daily for 3-4 weeks.
Other Names:
  • calcium tables
  • Placebo Comparator: Obsessive-Compulsive Disorder Control Group

    The OCD placebo control group will be administered the exact same procedure as the intervention group, the only difference being that this group will be administered a placebo tablet.

    Drug: Placebo oral tablet
    20mg placebo tablet daily for 3-4 weeks.
    Other Names:
  • calcium tables
  • Experimental: Healthy Intervention Group

    The healthy intervention group will be administered 20mg of Escitalopram daily for 3-4 weeks.

    Drug: Escitalopram
    20mg daily for 3-4 weeks.
    Other Names:
  • Escitalopram STADA
  • Experimental: Obsessive-Compulsive Disorder Intervention Group

    The healthy intervention group will be administered 20mg of Escitalopram daily for 3-4 weeks.

    Drug: Escitalopram
    20mg daily for 3-4 weeks.
    Other Names:
  • Escitalopram STADA
  • Outcome Measures

    Primary Outcome Measures

    1. Learning Primary Outcome 1 measured with Probability Reversal Learning test: Mean errors Stage 1 (Learning) [3 years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    2. Learning Primary Outcome 2 measured with Probability Reversal Learning test: Mean errors Stage 2 (Reversal) [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    3. Learning Primary Outcome 3 measured with Deterministic Reversal Learning test: Percent correct per stage [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    4. Inhibition Primary Outcome 1 measured with Interleaved Stop Signal Task/Go-NoGo: Stop Signal Reaction Time [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    5. Flexibility Primary Outcome 1 measured with 3Dimensional Intra/Extra Dimensional Shift test: Extra Dimensional Set Errors [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    6. Flexibility Primary Outcome 2 measured with Sequential model-based model-free test: Model-based Model-free Weight [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    7. Social Cognition Primary Outcome 1 measured with EMOTICOM Moral Emotions Task: Agent Guilt Score [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    8. Social Cognition Primary Outcome 2 measured with EMOTICOM Moral Emotions Task: Agent Shame Score [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. The false discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    9. Emotion Recognition Primary Outcome 1 measures with EMOTICOM Intensity Morphing: Affective bias in decreasing condition [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    10. Emotion Recognition Primary Outcome 2 measured with EMOTICOM Emotion Recognition Task: Affective bias for D' [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    11. Emotion Recognition Primary Outcome 3 measured with EMOTICOM Intensity Morphing task: Detection threshold decreasing [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    12. Emotion Recognition Primary Outcome 4 measured with EMOTICOM Emotion Recognition task: D'Prime for emotion recognition [3 Years]

      Emotion Recognition Task. Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    13. Memory Primary Outcome 1 measured with CANTAB Paired Associates Learning: Total Errors Adj [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    14. Biofluids [3 Years]

      Serum Escitalopram levels

    15. Positron emission tomography (PET) Imaging: Cerebral [11C]SB207145 PET binding. [3 Years]

      Collected before and after participant's intervention.

    16. Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Slip of Actions [3 Years]

      Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.

    17. Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Cohabit [3 Years]

      Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12Co-habit fMRI paradigm Imaging outcomes will be FWE corrected using Random Field Theory as implemented in SPM12.

    18. Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Faces [3 Years]

      Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.

    19. Resting State fMRI [3 Years]

      Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.

    20. Structural Voxel-based morphometry (VBM) MRI [3 Years]

      Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.

    21. Diffusion Tensor Imaging MRI [3 Years]

    22. Habit formation outcome 1: response times for each day of training [3 Years]

      Daily app training paradigm

    23. Habit formation outcome 2: mean errors per sequence and moves [3 Years]

      Daily app training paradigm

    24. Habit formation outcome 3: confidence and enjoyable rates. [3 Years]

      Daily app training paradigm

    Secondary Outcome Measures

    1. Learning Secondary Outcome 1 measured with Probability Reversal Learning test: Stage 1 Reward-Stay/Lose-Shift behaviour [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    2. Learning Secondary Outcome 2 measured with Probability Reversal Learning test: Stage 1 Reward/Punishment learning [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    3. Learning Secondary Outcome 3 measured with Probability Reversal Learning test: Stage 1. Stimulus Stickiness [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    4. Learning Secondary Outcome 4 measured with Probability Reversal Learning test: Stage 2 Reward-Stay/ Lose-Shift behaviour [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    5. Learning Secondary Outcome 5 measured with Probability Reversal Learning test: Stage 2 Reward/Punishment learning [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    6. Learning Secondary Outcome 6 measured with Probability Reversal Learning test: Stage 2. Stimulus Stickiness [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    7. Learning Secondary Outcome 7 measured with Deterministic Reversal Learning test: Reward-Stay/ Lose-Shift behaviour [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    8. Flexibility Secondary Outcome 1 measured with Sequential Model-Based/Model-Free test: Proportion of Stays [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    9. Flexibility Secondary Outcome 2 measured with Sequential Model-Based/Model-Free test: Exploration [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    10. Flexibility Secondary Outcome 3 measured with Sequential Model-Based/Model-Free test: Stimulus Stickiness [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    11. Flexibility Secondary Outcome 4 measured with Sequential Model-Based/Model-Free test: Learning rate [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    12. Flexibility Secondary Outcome 5 measured with 3Dimensional Intra/Extra Dimensional Shift test: Pre Extra Dimension Set Errors [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    13. Flexibility Secondary Outcome 6 measured with 3Dimensional Intra/Extra Dimensional Shift test: Latency [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    14. Inhibition Secondary Outcome 1 measured with Interleaved Stop Signal Task/Go-NoGo: Go reaction time [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    15. Inhibition Secondary Outcome 2 measured with Interleaved Stop Signal Task/Go-NoGo: Go omission error rate [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    16. Inhibition Secondary Outcome 3 measured with Interleaved Stop Signal Task/Go-NoGo: Go commission error rate [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    17. Inhibition Secondary Outcome 4 measured with Interleaved Stop Signal Task/Go-NoGo: No-Go error rate [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    18. Executive Function Secondary Outcome 1 measured with 3Dimensional Intra/Extra Dimensional Shift test: Total Errors Adjusted [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    19. Emotion Recognition Secondary Outcome 1 measured with EMOTICOM Intensity Morphing Task: Detection threshold increasing [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    20. Emotion Recognition Secondary Outcome 2 measured with EMOTICOM Intensity Morphing Task: Affective bias in increasing condition [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    21. Emotion Recognition Secondary Outcome 3 measured with EMOTICOM Emotion Recognition Task: Affective bias for Hit Rate [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    22. Emotion Recognition Secondary Outcome 4 measured with EMOTICOM Emotion Recognition Task.: Hit Rate for Emotion Recognition [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    23. Faces and geometric figure discrimination Outcome 1 measured with fMRI faces paradigm: Accuracy [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    24. Behavioural outcomes with Faces and geometric figure discrimination Outcome 2 measured with fMRI faces paradigm: Response Speed [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    25. Behavioural outcomes with fMRI paradigm slip of Actions : accuracy and latency [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    26. Behavioural outcomes with fMRI paradigm Co-habit: accuracy and latency. [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    27. Memory Outcome 1 measured with CANTAB Paired Associates Learning test: First Trial Memory Score [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    28. Memory Outcome 2 measured with Letter-number sequencing test: Total score [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    29. Memory Primary outcome 3 measured with Verbal Affective Memory Test-26: Latent variable model of the association between positive, negative and neutral word recall and 5-HT4R binding [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    30. Risky Decision Making Outcome Outcome 1 measured with EMOTICOM Cambridge Gamble Task: Quality of Decision Making [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    31. Risky Decision Making Outcome 2 measured with EMOTICOM Cambridge Gamble Task: Risk Adjustment [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    32. Risky Decision Making Outcome 3 measured with EMOTICOM Cambridge Gamble Task: Overall Proportion Bet [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    33. Risky Decision Making Outcome 4 measured with EMOTICOM Cambridge Gamble Task: Deliberation Time [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    34. Psychomotor Speed Outcome 1 measured with CANTAB Reaction Time Task: Simple reaction time [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

    35. Intelligence Quotient (IQ) outcome 1 measured with Reynolds Intellectual assessment Scales subtest "guess what" and "what does not fit": Total age adjusted score [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain

    36. Interpersonal Reactivity Index (IRI) Score [3 Years]

    37. Obsessive- Compulsive Inventory (OCI)- state Score [3 Years]

    38. Obsessive- Compulsive Inventory- trait Score [3 Years]

    39. Brief Symptom Inventory (BSI) Score [3 Years]

    40. Pittsburgh Sleep Quality Index Score [3 Years]

    41. Profile of Mood State Score [3 Years]

    42. Beck Depression Inventory-II Score [3 Years]

      Contain 21-items, scored on a scale value of 0 to 3

    43. State-Trait Anxiety Inventory Scale Score [3 Years]

      Contain 40-items

    44. State and Trait Aggression Questionnaire Score [3 Years]

    45. Barratt Impulsiveness Scale-State Score [3 Years]

    46. Visual Analogue Scale Score [3 Years]

    Other Outcome Measures

    1. Emotion Recognition Other Outcome 1: Detection threshold decreasing Happy - Intensity Morphing [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    2. Emotion Recognition Other Outcome 2: Detection threshold decreasing Sad - Intensity Morphing [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    3. Emotion Recognition Other Outcome 3: Detection threshold decreasing Anger - Intensity Morphing [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    4. Emotion Recognition Other Outcome 4: Detection threshold decreasing Fear - Intensity Morphing [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    5. Emotion Recognition Other Outcome 5: Detection threshold decreasing Disgust - Intensity Morphing [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    6. Emotion Recognition Other Outcome 6: D' Happy - Emotion Recognition Task [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    7. Emotion Recognition Other Outcome 7: D' Sad - Emotion Recognition Task [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    8. Emotion Recognition Other Outcome 8: D' Fear - Emotion Recognition Task [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    9. Emotion Recognition Other Outcome 9: D' Anger - Emotion Recognition Task [3 Years]

      Outcome variables have been grouped a priori into carefully defined cognitive domains.

    10. Activity Level Score [3 Years]

    11. Behavioural Inhibition/ Behavioural Avoidance Scale Score [3 Years]

    12. The Compulsive Personality Assessment Scale Score [3 Years]

    13. Sexuality Questionnaire Score [3 Years]

    14. Edinburgh Handedness Inventory Score [3 Years]

    15. Revised NEO Personality Questionnaire Score [3 Years]

    16. Family History Assessment Module Score [3 Years]

    17. Positive Life Events Score [3 Years]

    18. Stressful Life Events Score [3 Years]

    19. Perceived stress scale [3 Years]

    20. Barratt Impulsiveness Scale-Trait Score [3 Years]

    21. The Penn State Worry Questionnaire- Trait Score [3 Years]

    22. The Penn State Worry Questionnaire- State Score [3 Years]

    23. The Self-Control Scale- Trait Score [3 Years]

    24. The Self-Control Scale- State Score [3 Years]

    25. State- Trait Anxiety Inventory- Trait Score [3 Years]

    26. The Warwick-Edinburgh Mental Well-being Scale -State Score [3 Years]

    27. The Warwick-Edinburgh Mental Well-being Scale -Trait Score [3 Years]

    28. Mindful Attention and Awareness Scale -State Score [3 Years]

    29. Mindful Attention and Awareness Scale -Trait Score [3 Years]

    30. The Intolerance of Uncertainty Scale - Trait Score [3 Years]

    31. The Intolerance of Uncertainty Scale - State Score [3 Years]

    32. Verran and Snyder-Halpern (VSH) Sleep Scale Score [3 Years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • OCD patients and healthy volunteers (male or female) between 18 and 70 years.
    Exclusion Criteria:
    • Current or previous neurological disease, severe somatic disease, or consumption of medical drugs likely to influence the test results

    • Non- fluent in Danish or pronounced visual or auditory impairments

    • Current or past learning disability.

    • Pregnancy (females).

    • Lactation (females).

    • Participation in experiments with radioactivity (> 10 mSv) within the last year or significant occupational exposure to radioactivity.

    • Contraindications for MRI (pacemaker, metal implants, etc.).

    • Allergy to the ingredients in the administered drug.

    • Abnormal ECG (e.g. prolonged QT syndrome).

    • Dizzy when changing from supine to upright position (e.g. postural orthostatic tachycardia syndrome).

    • Mild hypotension (blood pressure below 100/70 mmHg) or hypertension (blood pressure above 140/90 mmHg).

    • Head injury or concussion resulting in loss of consciousness for more than 2 min.

    • Alcohol or drug abuse

    • Drug use other than tobacco and alcohol within the last 30 days.

    • Hash > 50 x lifetime.

    • Drugs > 10 x lifetime (for each substance).

    • Current medication with serotonergic acting compounds. Use of other psychoactive substances must be stable at least one month prior to inclusion and maintained throughout the study.

    • Severe physical impairments affecting eyesight or motor performance.

    • For the OCD group: other Axis I mental disorder as primary diagnosis according to ICD-10 criteria.

    • For healthy volunteers: any current or former primary psychiatric disorder (Axis I WHO ICD-10 diagnostic classification).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Neurobiology Research Unit, Rigshospitalet Copenhagen Denmark 2100

    Sponsors and Collaborators

    • Rigshospitalet, Denmark
    • University of Cambridge
    • Lundbeck Foundation

    Investigators

    • Study Chair: Gitte M. Knudsen, Professor, Neurobiology Research Unit, Rigshospitalet

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Gitte Moos Knudsen, Professor, MD, DMSc, Rigshospitalet, Denmark
    ClinicalTrials.gov Identifier:
    NCT04336228
    Other Study ID Numbers:
    • H-18038325
    First Posted:
    Apr 7, 2020
    Last Update Posted:
    Aug 11, 2020
    Last Verified:
    Aug 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Gitte Moos Knudsen, Professor, MD, DMSc, Rigshospitalet, Denmark
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 11, 2020